Published ahead of print on February 2, 2006, doi:10.1164/rccm.200510-1668OC
Am. J. Respir. Crit. Care Med., Volume 173, Number 9, May 2006, 1023-1030
A more recent version of this article appeared on May 1, 2006
Submitted on October 26, 2005
Accepted on February 2, 2006
Pulmonary Arterial Hypertension in France : Results from a National Registry
Marc Humbert1*, Olivier Sitbon1, Ari Chaouat2, Michele Bertocchi3, Gilbert Habib4, Virginie Gressin5, Azzedine Yaici1, Emmanuel Weitzenblum2, Jean-Francois Cordier3, Francois Chabot6, Claire Dromer7, Christophe Pison8, Martine Reynaud-Gaubert9, Alain Haloun10, Marcel Laurent11, Eric Hachulla12, and Gerald Simonneau1
1 Service de Pneumologie, Centre des Maladies Vasculaires Pulmonaires, UPRES EA2705, Hopital Antoine-Beclere, Assistance-Publique-Hopitaux de Paris, Univeriste Paris-Sud, Clamart, France,
2 Service de Pneumologie, Hopital Hautepierre, Strasbourg, France,
3 Service de Pneumologie, Hopital Louis-Pradel, Lyon, France,
4 Service de Cardiologie, Hopital de la Timone, Marseille, France,
5 Actelion Pharmaceuticals France, Paris, France,
6 Service de Pneumologie, Hopital de Brabois, Vandoeuvre-les-Nancy, France,
7 Service de Chirurgie Thoracique, Hopital du Haut Levesque, Bordeaux, France,
8 Departement Medecine Aigue Specialisee, Hopital Michallon, Grenoble, France,
9 Service de Pneumologie, UPRES EA3287, Hopital Sainte Marguerite, Marseille, France,
10 Service de Pneumologie, Hopital Laennec, Nantes, France,
11 Service de Cardiologie, Hopital Pontchaillou, Rennes, France,
12 Service de Medecine Interne, Hopital Claude Huriez, Lille, France
* To whom correspondence should be addressed. E-mail: marc.humbert{at}abc.aphp.fr.
Rationale. Pulmonary arterial hypertension is an orphan disease for which the trend is for management in designated centers with multidisciplinary teams working in a shared-care approach. Objective. To describe clinical and hemodynamic parameters and to provide estimates for the prevalence of patients diagnosed for pulmonary arterial hypertension according to a standardised definition. Methods. The registry was initiated in 17 university hospitals following at least 5 newly diagnosed patients per year. All consecutive adult ( 18 years) patients seen between October 2002 and October 2003 were to be included. Main Results. 674 patients (mean±SD age of 50±15 years (range 18-85)) were entered in the registry. Idiopathic, familial, anorexigen, connective tissue diseases, congenital heart diseases, portal hypertension and human immunodeficiency virus infection-associated pulmonary arterial hypertension accounted for 39.2%, 3.9%, 9.5%, 15.3%, 11.3%, 10.4% and 6.2% of the population, respectively. At diagnosis, 75% of patients were in New York Heart Association functional class III or IV. Six-minute walk test was 329±109 meters. Mean pulmonary artery pressure, cardiac index and pulmonary vascular resistance index were 55±15 mmHg, 2.5±0.8 L/min/m2, and 20.5±10.2 mmHg/L/min/m2, respectively. The low estimates of prevalence and incidence of pulmonary arterial hypertension in France were 15.0 cases/million of adult inhabitants and 2.4 cases/million of adult inhabitants/year. One-year survival was 88% in the incident cohort. Conclusions. This contemporary registry highlights current practice and shows that pulmonary arterial hypertension is still detected late in the course of the disease with a majority of patients displaying severe functional and hemodynamic compromise.
Key words: Cardiopulmonary hemodynamics, Prevalence, Pulmonary Arterial Hypertension, Registry, Six-minute walk test
This article has been cited by other articles:

|
 |

|
 |
 
S. L. Archer and E. D. Michelakis
Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension
N. Engl. J. Med.,
November 5, 2009;
361(19):
1864 - 1871.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J.-L. Vachiery, J. A. Barbera, M. Beghetti, P. Corris, S. Gaine, et al.
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
Eur. Heart J.,
October 2, 2009;
30(20):
2493 - 2537.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kovacs, A. Berghold, S. Scheidl, and H. Olschewski
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review
Eur. Respir. J.,
October 1, 2009;
34(4):
888 - 894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Gatzoulis, R. Alonso-Gonzalez, and M. Beghetti
Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease
Eur. Respir. Rev.,
September 1, 2009;
18(113):
154 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J-L. Vachiery and G. Coghlan
Screening for pulmonary arterial hypertension in systemic sclerosis
Eur. Respir. Rev.,
September 1, 2009;
18(113):
162 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rubenfire, G. Lippo, B. D. Bodini, F. Blasi, L. Allegra, and E. Bossone
Evaluating Health-Related Quality of Life, Work Ability, and Disability in Pulmonary Arterial Hypertension: An Unmet Need
Chest,
August 1, 2009;
136(2):
597 - 603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Jackson and V. McLaughlin
The Metabolic Syndrome and Pulmonary Vascular Disease
Chest,
July 1, 2009;
136(1):
3 - 4.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Machado, O. Eickelberg, C. G. Elliott, M. W. Geraci, M. Hanaoka, J. E. Loyd, J. H. Newman, J. A. Phillips III, F. Soubrier, R. C. Trembath, et al.
Genetics and genomics of pulmonary arterial hypertension.
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1 Suppl):
S32 - S42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Badesch, H. C. Champion, M. A. Gomez Sanchez, M. M. Hoeper, J. E. Loyd, A. Manes, M. McGoon, R. Naeije, H. Olschewski, R. J. Oudiz, et al.
Diagnosis and assessment of pulmonary arterial hypertension.
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1 Suppl):
S55 - S66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Hoeper, J. A. Barbera, R. N. Channick, P. M. Hassoun, I. M. Lang, A. Manes, F. J. Martinez, R. Naeije, H. Olschewski, J. Pepke-Zaba, et al.
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1 Suppl):
S85 - S96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. V. McLaughlin, D. B. Badesch, M. Delcroix, T. R. Fleming, S. P. Gaine, N. Galie, J. S. R. Gibbs, N. H. Kim, R. J. Oudiz, A. Peacock, et al.
End Points and Clinical Trial Design in pulmonary arterial hypertension.
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1 Suppl):
S97 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Matucci-Cerinic, V. Steen, P. Nash, and E. Hachulla
The complexity of managing systemic sclerosis: screening and diagnosis
Rheumatology,
June 1, 2009;
48(suppl_3):
iii8 - iii13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. McLaughlin, M. Humbert, G. Coghlan, P. Nash, and V. Steen
Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis
Rheumatology,
June 1, 2009;
48(suppl_3):
iii25 - iii31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gomberg-Maitland
Something Subtle About Death: Isolated Systolic Pulmonary Pressure
Circulation,
May 26, 2009;
119(20):
2647 - 2649.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Roberts, M. B. Fallon, M. J. Krowka, R. S. Brown, J. F. Trotter, I. Peter, H. Tighiouart, J. A. Knowles, D. Rabinowitz, R. L. Benza, et al.
Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease
Am. J. Respir. Crit. Care Med.,
May 1, 2009;
179(9):
835 - 842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C L McGowan, J S Swiston, C F Notarius, S Mak, B L Morris, P E Picton, J T Granton, and J S Floras
Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension
Heart,
May 1, 2009;
95(9):
754 - 758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Shintani, H Yagi, T Nakayama, T Saji, and R Matsuoka
A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension
J. Med. Genet.,
May 1, 2009;
46(5):
331 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. V. McLaughlin, S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, R. S. Rosenson, et al.
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association
J. Am. Coll. Cardiol.,
April 28, 2009;
53(17):
1573 - 1619.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, V. V. McLaughlin, S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, et al.
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association
Circulation,
April 28, 2009;
119(16):
2250 - 2294.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Humbert
Update in Pulmonary Hypertension 2008
Am. J. Respir. Crit. Care Med.,
April 15, 2009;
179(8):
650 - 656.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Grimminger, G. Weimann, R. Frey, R. Voswinckel, M. Thamm, D. Bolkow, N. Weissmann, W. Muck, S. Unger, G. Wensing, et al.
First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension
Eur. Respir. J.,
April 1, 2009;
33(4):
785 - 792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lapa, B. Dias, C. Jardim, C. J.C. Fernandes, P. M.M. Dourado, M. Figueiredo, A. Farias, J. Tsutsui, M. Terra-Filho, M. Humbert, et al.
Cardiopulmonary Manifestations of Hepatosplenic Schistosomiasis
Circulation,
March 24, 2009;
119(11):
1518 - 1523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Humbert
More pressure on pulmonary hypertension
Eur. Respir. Rev.,
March 1, 2009;
18(111):
1 - 3.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Souza and C. Jardim
Trends in pulmonary arterial hypertension
Eur. Respir. Rev.,
March 1, 2009;
18(111):
7 - 12.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. PAMIDI and S. MEHTA
Six-Minute Walk Test in Scleroderma-Associated Pulmonary Arterial Hypertension: Are We Counting What Counts?
J Rheumatol,
February 1, 2009;
36(2):
216 - 218.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. McGoon and G. C. Kane
Pulmonary Hypertension: Diagnosis and Management
Mayo Clin. Proc.,
February 1, 2009;
84(2):
191 - 207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Condliffe, D. G. Kiely, A. J. Peacock, P. A. Corris, J. S. R. Gibbs, F. Vrapi, C. Das, C. A. Elliot, M. Johnson, J. DeSoyza, et al.
Connective Tissue Disease-associated Pulmonary Arterial Hypertension in the Modern Treatment Era
Am. J. Respir. Crit. Care Med.,
January 15, 2009;
179(2):
151 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Montani, L. C. Price, P. Dorfmuller, L. Achouh, X. Jais, A. Yaici, O. Sitbon, D. Musset, G. Simonneau, and M. Humbert
Pulmonary veno-occlusive disease
Eur. Respir. J.,
January 1, 2009;
33(1):
189 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Degano, A. Yaici, J. Le Pavec, L. Savale, X. Jais, B. Camara, M. Humbert, G. Simonneau, and O. Sitbon
Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension
Eur. Respir. J.,
January 1, 2009;
33(1):
92 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Galiè and A. Manes
CHAPTER 24 Pulmonary Hypertension
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chaouat, R. Naeije, and E. Weitzenblum
Pulmonary hypertension in COPD
Eur. Respir. J.,
November 1, 2008;
32(5):
1371 - 1385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Butrous, H. A. Ghofrani, and F. Grimminger
Pulmonary Vascular Disease in the Developing World
Circulation,
October 21, 2008;
118(17):
1758 - 1766.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Humbert and M. M. Hoeper
Severe Pulmonary Arterial Hypertension: A Forme Fruste of Cancer?
Am. J. Respir. Crit. Care Med.,
September 15, 2008;
178(6):
551 - 552.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Le Pavec, R. Souza, P. Herve, D. Lebrec, L. Savale, C. Tcherakian, X. Jais, A. Yaici, M. Humbert, G. Simonneau, et al.
Portopulmonary Hypertension: Survival and Prognostic Factors
Am. J. Respir. Crit. Care Med.,
September 15, 2008;
178(6):
637 - 643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. McGoon, A. Krichman, H. W. Farber, R. J. Barst, G. E. Raskob, T. G. Liou, D. P. Miller, K. Feldkircher, and S. Giles
Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension
Mayo Clin. Proc.,
August 1, 2008;
83(8):
923 - 931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gomberg-Maitland
Traditional and Alternative Designs for Pulmonary Arterial Hypertension Trials
Proceedings of the ATS,
July 15, 2008;
5(5):
610 - 616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Sztrymf, F. Coulet, B. Girerd, A. Yaici, X. Jais, O. Sitbon, D. Montani, R. Souza, G. Simonneau, F. Soubrier, et al.
Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation
Am. J. Respir. Crit. Care Med.,
June 15, 2008;
177(12):
1377 - 1383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Shah, T. Thenappan, S. Rich, L. Tian, S. L. Archer, and M. Gomberg-Maitland
Association of Serum Creatinine With Abnormal Hemodynamics and Mortality in Pulmonary Arterial Hypertension
Circulation,
May 13, 2008;
117(19):
2475 - 2483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Chin and L. J. Rubin
Pulmonary arterial hypertension.
J. Am. Coll. Cardiol.,
April 22, 2008;
51(16):
1527 - 1538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Humbert
Update in Pulmonary Arterial Hypertension 2007
Am. J. Respir. Crit. Care Med.,
March 15, 2008;
177(6):
574 - 579.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Souza, M. Humbert, B. Sztrymf, X. Jais, A. Yaici, J. Le Pavec, F. Parent, P. Herve, F. Soubrier, O. Sitbon, et al.
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases
Eur. Respir. J.,
February 1, 2008;
31(2):
343 - 348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Sitbon, C. Lascoux-Combe, J.-F. Delfraissy, P. G. Yeni, F. Raffi, D. De Zuttere, V. Gressin, P. Clerson, D. Sereni, and G. Simonneau
Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era
Am. J. Respir. Crit. Care Med.,
January 1, 2008;
177(1):
108 - 113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Kawut
Caring for the orphan's orphan: treatment of patients with portopulmonary hypertension
Eur. Respir. J.,
December 1, 2007;
30(6):
1038 - 1040.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Thenappan, S. J. Shah, S. Rich, and M. Gomberg-Maitland
A USA-based registry for pulmonary arterial hypertension: 1982 2006
Eur. Respir. J.,
December 1, 2007;
30(6):
1103 - 1110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tino
Clinical Year in Review I: Lung Cancer, Interventional Pulmonology, Pediatric Pulmonary Disease, and Pulmonary Vascular Disease
Proceedings of the ATS,
September 15, 2007;
4(6):
478 - 481.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Helman Jr, A. W. Brown, J. L. Jackson, and A. F. Shorr
Analyzing the Short-term Effect of Placebo Therapy in Pulmonary Arterial Hypertension: Potential Implications for the Design of Future Clinical Trials
Chest,
September 1, 2007;
132(3):
764 - 772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Gaine and J. Behr
Confidence from experience: dual endothelin receptor antagonism in PAH
Eur. Respir. Rev.,
August 1, 2007;
16(102):
1 - 2.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Humbert, N. Khaltaev, J. Bousquet, and R. Souza
Pulmonary Hypertension: From an Orphan Disease to a Public Health Problem
Chest,
August 1, 2007;
132(2):
365 - 367.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-C. Jing, X.-Q. Xu, Z.-Y. Han, Y. Wu, K.-W. Deng, H. Wang, Z.-W. Wang, X.-S. Cheng, B. Xu, S.-S. Hu, et al.
Registry and Survival Study in Chinese Patients With Idiopathic and Familial Pulmonary Arterial Hypertension
Chest,
August 1, 2007;
132(2):
373 - 379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Humbert
The burden of pulmonary hypertension
Eur. Respir. J.,
July 1, 2007;
30(1):
1 - 2.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Peacock, N. F. Murphy, J. J. V. McMurray, L. Caballero, and S. Stewart
An epidemiological study of pulmonary arterial hypertension
Eur. Respir. J.,
July 1, 2007;
30(1):
104 - 109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. McMurtry, R. Moudgil, K. Hashimoto, S. Bonnet, E. D. Michelakis, and S. L. Archer
Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension
Am J Physiol Lung Cell Mol Physiol,
April 1, 2007;
292(4):
L872 - L878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rich
How Do We Explain Unexplained Pulmonary Hypertension in the Elderly?
Chest,
January 1, 2007;
131(1):
5 - 6.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Krowka and K. L. Swanson
How should we treat portopulmonary hypertension?
Eur. Respir. J.,
September 1, 2006;
28(3):
466 - 467.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Marecki, C. D. Cool, J. E. Parr, V. E. Beckey, P. A. Luciw, A. F. Tarantal, A. Carville, R. P. Shannon, A. Cota-Gomez, R. M. Tuder, et al.
HIV-1 Nef Is Associated with Complex Pulmonary Vascular Lesions in SHIV-nef-infected Macaques
Am. J. Respir. Crit. Care Med.,
August 15, 2006;
174(4):
437 - 445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Souza, C. Jardim, and C. Carvalho
The Need for National Registries in Rare Diseases
Am. J. Respir. Crit. Care Med.,
July 15, 2006;
174(2):
228 - 228.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Humbert, G. Simonneau, and on behalf of the French Network on Pulmonary Arter
The Need for National Registries in Rare Diseases
Am. J. Respir. Crit. Care Med.,
July 15, 2006;
174(2):
228a - 229.
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 American Thoracic Society
|
|
|